These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 8247254

  • 1. The effect of salt-loading on corticotropin releasing hormone and arginine vasopressin mRNA levels in the mouse hypothalamus: a quantitative in situ hybridization analysis.
    Tracer HL, Loh YP.
    Neuropeptides; 1993 Sep; 25(3):161-7. PubMed ID: 8247254
    [Abstract] [Full Text] [Related]

  • 2. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
    Ogilvie KM, Lee S, Rivier C.
    Brain Res; 1997 Jan 02; 744(1):83-95. PubMed ID: 9030416
    [Abstract] [Full Text] [Related]

  • 3. The effects of estrogen and progesterone on corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid levels in the paraventricular nucleus and supraoptic nucleus of the rhesus monkey.
    Roy BN, Reid RL, Van Vugt DA.
    Endocrinology; 1999 May 02; 140(5):2191-8. PubMed ID: 10218971
    [Abstract] [Full Text] [Related]

  • 4. The effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on corticotrophin-releasing hormone, arginine vasopressin, and pro-opiomelanocortin mRNA levels in the hypothalamus of the cynomolgus monkey.
    Shridhar S, Farley A, Reid RL, Foster WG, Van Vugt DA.
    Toxicol Sci; 2001 Oct 02; 63(2):181-8. PubMed ID: 11568361
    [Abstract] [Full Text] [Related]

  • 5. Histaminergic activation of the hypothalamic-pituitary-adrenal axis.
    Kjaer A, Larsen PJ, Knigge U, Warberg J.
    Endocrinology; 1994 Sep 02; 135(3):1171-7. PubMed ID: 8070360
    [Abstract] [Full Text] [Related]

  • 6. Expression of the arginine vasopressin gene in response to salt loading in oxytocin gene knockout mice.
    Ozaki Y, Nomura M, Saito J, Luedke CE, Muglia LJ, Matsumoto T, Ogawa S, Ueta Y, Pfaff DW.
    J Neuroendocrinol; 2004 Jan 02; 16(1):39-44. PubMed ID: 14962074
    [Abstract] [Full Text] [Related]

  • 7. Thyroxine modulates corticotropin-releasing factor but not arginine vasopressin gene expression in the hypothalamic paraventricular nucleus of the developing Rat.
    Dakine N, Oliver C, Grino M.
    J Neuroendocrinol; 2000 Aug 02; 12(8):774-83. PubMed ID: 10929090
    [Abstract] [Full Text] [Related]

  • 8. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
    Herman JP, Wiegand SJ, Watson SJ.
    Endocrinology; 1990 Nov 02; 127(5):2408-17. PubMed ID: 2171915
    [Abstract] [Full Text] [Related]

  • 9. Effects of experimental hypothyroidism on the development of the hypothalamo-pituitary-adrenal axis in the rat.
    Dakine N, Oliver C, Grino M.
    Life Sci; 2000 Oct 27; 67(23):2827-44. PubMed ID: 11105998
    [Abstract] [Full Text] [Related]

  • 10. Effects of hyperosmotic stimulation and adrenalectomy on vasopressin mRNA levels in the paraventricular and supraoptic nuclei of the hypothalamus: in situ hybridization histochemical analysis using a synthetic oligonucleotide probe.
    Suemaru S, Hashimoto K, Ogasa T, Takao T, Ota Z, Hirakawa M, Kawata M.
    Acta Med Okayama; 1990 Oct 27; 44(5):233-41. PubMed ID: 2260495
    [Abstract] [Full Text] [Related]

  • 11. Vasopressin and oxytocin neurones of hypothalamic supraoptic and paraventricular nuclei co-express mRNA for Type-1 and Type-2 corticotropin-releasing hormone receptors.
    Arima H, Aguilera G.
    J Neuroendocrinol; 2000 Sep 27; 12(9):833-42. PubMed ID: 10971808
    [Abstract] [Full Text] [Related]

  • 12. Androgens alter corticotropin releasing hormone and arginine vasopressin mRNA within forebrain sites known to regulate activity in the hypothalamic-pituitary-adrenal axis.
    Viau V, Soriano L, Dallman MF.
    J Neuroendocrinol; 2001 May 27; 13(5):442-52. PubMed ID: 11328455
    [Abstract] [Full Text] [Related]

  • 13. Effects of adrenalectomy and type I or type II glucocorticoid receptor activation on AVP and CRH mRNA in the rat hypothalamus.
    Albeck DS, Hastings NB, McEwen BS.
    Brain Res Mol Brain Res; 1994 Oct 27; 26(1-2):129-34. PubMed ID: 7854039
    [Abstract] [Full Text] [Related]

  • 14. Hypothalamo-pituitary-adrenal axis sensitization after chronic salt loading.
    Amaya F, Tanaka M, Hayashi S, Tanaka Y, Ibata Y.
    Neuroendocrinology; 2001 Mar 27; 73(3):185-93. PubMed ID: 11307037
    [Abstract] [Full Text] [Related]

  • 15. Upregulation of CRH gene expression and downregulation of arginine vasopressin gene expression in the hypothalamus of bilateral nephrectomized rats.
    Nomura M, Serino R, Yamamoto Y, Ozaki Y, Saito J, Matsumoto T, Yamashita H, Ueta Y.
    Life Sci; 2002 Dec 20; 72(4-5):501-9. PubMed ID: 12467890
    [Abstract] [Full Text] [Related]

  • 16. Centrally administered murine-leptin stimulates the hypothalamus-pituitary- adrenal axis through arginine-vasopressin.
    Morimoto I, Yamamoto S, Kai K, Fujihira T, Morita E, Eto S.
    Neuroendocrinology; 2000 Jun 20; 71(6):366-74. PubMed ID: 10878498
    [Abstract] [Full Text] [Related]

  • 17. The magnocellular arginine-vasopressin mRNA responds differently to food deprivation between the supraoptic and paraventricular nuclei of the hypothalamus in adrenalectomized rats with low corticosterone replacement.
    Ogasa T, Hashimoto K, Suemaru S, Kageyama J, Ota Z.
    Brain Res; 1992 Jun 26; 583(1-2):45-53. PubMed ID: 1504843
    [Abstract] [Full Text] [Related]

  • 18. Enhanced up-regulation of corticotropin-releasing hormone gene expression in response to restraint stress in the hypothalamic paraventricular nucleus of oxytocin gene-deficient male mice.
    Nomura M, Saito J, Ueta Y, Muglia LJ, Pfaff DW, Ogawa S.
    J Neuroendocrinol; 2003 Nov 26; 15(11):1054-61. PubMed ID: 14622435
    [Abstract] [Full Text] [Related]

  • 19. Effects of vasopressin and elimination of corticotropin-releasing hormone-target cells on pro-opiomelanocortin mRNA levels and adrenocorticotropin secretion in ovine anterior pituitary cells.
    van de Pavert SA, Clarke IJ, Rao A, Vrana KE, Schwartz J.
    J Endocrinol; 1997 Jul 26; 154(1):139-47. PubMed ID: 9246948
    [Abstract] [Full Text] [Related]

  • 20. Expression of corticotropin releasing factor (CRF), urocortin and CRF type 1 receptors in hypothalamic-hypophyseal systems under osmotic stimulation.
    Imaki T, Katsumata H, Miyata M, Naruse M, Imaki J, Minami S.
    J Neuroendocrinol; 2001 Apr 26; 13(4):328-38. PubMed ID: 11264720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.